Neuro-Oncology Reviews
Volume
26 Number 8
30 April 2024
Home > Publications > Neuro-Oncology Reviews > Volume 26, Year 2024 > Number 8, 30 April
Knopik-Skrocka A, Sempowicz A, Piwocka O.
Plasticity
and resistance of cancer stem cells as a challenge for innovative
anticancer therapies - do we know enough to overcome this?
EXCLI
J. 2024 Feb 29;23:335-355. doi:
10.17179/excli2024-6972. PMID:
38655094. Review. ˍ
**Czarnywojtek A, Gut P, Dyrka K, Sowiński J, Sawicka-Gutaj
N, Katulska K, Stajgis P, Wykrętowicz M, Moskal J, Kościński
J, Pietrończyk K, Graczyk P, Krawczyński MR, Florek E,
Szczepanek-Parulska E, Ruchała M, Ferlito A.
Standard
therapy or additionally radioactive iodine (131I) therapy; which
will stop the recurrence of glioblastoma multiforme
(GBM)?
Endokrynol
Pol. 2024 Mar 19. doi:
10.5603/ep.98240. PMID:
38646982. Case report; Review. ˍ
Ohnishi T.
Current Status and Future
Perspective in Glioma Invasion Research.
Brain
Sci. 2024 Mar 26;14(4):309. doi:
10.3390/brainsci14040309. PMID:
38671961. Editorial. ˍ
Schirrmacher V, Van Gool S, Stuecker W.
Individualized
Multimodal Immunotherapy (IMI): Scientific Rationale and Clinical
Experience from a Single Institution.
Biomedicines.
2024 Mar 28;12(4):754. doi:
10.3390/biomedicines12040754. PMID:
38672110. Review. ˍ
Virtuoso A, D'Amico G, Scalia F, De Luca C, Papa M, Maugeri G,
D'Agata V, Caruso Bavisotto C, D'Amico AG.
The
Interplay between Glioblastoma Cells and Tumor Microenvironment:
New Perspectives for Early Diagnosis and Targeted Cancer
Therapy.
Brain
Sci. 2024 Mar 29;14(4):331. doi:
10.3390/brainsci14040331. PMID:
38671983. Review. ˍ
Katole VR, Kaple M.
Unraveling the
Landscape of Pediatric Glioblastoma Biomarkers: A Comprehensive
Review of Enhancing Diagnostics and Therapeutic Insights.
Cureus.
2024 Mar 30;16(3):e57272. doi:
10.7759/cureus.57272. PMID:
38686271. Review. ˍ
He W, Wang N, Wang Y, Liu M, Qing Q, Su Q, Zou Y, Liu
Y.
Engineering Nanomedicine for
Non-Viral RNA-Based Gene Therapy of Glioblastoma.
Pharmaceutics.
2024 Apr 1;16(4):482. doi:
10.3390/pharmaceutics16040482. PMID:
38675144. Review. ˍ
Calderón-Peláez MA, Maradei Anaya SJ,
Bedoya-Rodríguez IJ, González-Ipuz KG, Vera-Palacios
D, Buitrago IV, Castellanos JE, Velandia-Romero ML.
Zika
Virus: A Neurotropic Warrior against High-Grade Gliomas-Unveiling
Its Potential for Oncolytic Virotherapy.
Viruses.
2024 Apr 3;16(4):561. doi:
10.3390/v16040561. PMID:
38675903;. Review. ˍ
Ghimire P, Kinnersley B, Karami G, Arumugam P, Houlston R, Ashkan
K, Modat M, Booth TC.
Radiogenomic
biomarkers for immunotherapy in glioblastoma: A systematic review
of magnetic resonance imaging studies.
Neurooncol
Adv. 2024 Apr 5;6(1):vdae055. doi:
10.1093/noajnl/vdae055. PMID:
38680991. Review. ˍ
Chen X, Cui Y, Zou L.
Treatment
advances in high-grade gliomas.
Front
Oncol. 2024 Apr 10;14:1287725. doi:
10.3389/fonc.2024.1287725. PMID:
38660136. Review. ˍ
Pallarés-Moratalla C, Bergers G.
The
ins and outs of microglial cells in brain health and
disease.
Front
Immunol. 2024 Apr 11;15:1305087. doi:
10.3389/fimmu.2024.1305087. PMID:
38665919. Review. ˍ
*Won SE, Suh CH, Kim S, Park HJ, Kim KW.
Summary
of Key Points of the Response Assessment in Neuro-Oncology (RANO)
2.0.
Korean
J Radiol. 2024 Apr 11. doi:
10.3348/kjr.2024.0016. PMID:
38627876. Editorial. ˍ
Anichini G, Leiloglou M, Hu Z, O'Neill K, Daniel
Elson.
Hyperspectral and multispectral
imaging in neurosurgery: a systematic literature review and
meta-analysis.
Eur
J Surg Oncol. 2024 Apr 12:108293. doi:
10.1016/j.ejso.2024.108293. PMID:
38658267. Review˰ ˍ
Rios SA, Oyervides S, Uribe D, Reyes AM, Fanniel V, Vazquez J,
Keniry M.
Emerging Therapies for
Glioblastoma.
Cancers
(Basel). 2024 Apr 12;16(8):1485. doi:
10.3390/cancers16081485. PMID:
38672566.
Review.
ˍ
D'Alessandris QG, Offi M, Lauretti L, Pallini R.
Personalized
Medicine in Brain Tumors.
J
Pers Med. 2024 Apr 13;14(4):413. doi:
10.3390/jpm14040413. PMID:
38673040. Editorial. ˍ
Wang S, Gu S, Chen J, Yuan Z, Liang P, Cui H.
Mechanism
of Notch Signaling Pathway in Malignant Progression of
Glioblastoma and Targeted Therapy.
Biomolecules.
2024 Apr 15;14(4):480. doi:
10.3390/biom14040480. PMID:
38672496.
Review.
ˍ
Cohen
KJ,
et al, PDQ Pediatric Treatment Editorial Board.
Childhood
Ependymoma Treatment (PDQ®): Health Professional Version.
PDQ
Cancer Inf Summ.
2024
Apr 16.
NCBI
Bookshelf ID:
NBK65935.
PMID:
26389373.
Review.
ˍ
Ramírez-Ferrer E, Aguilera-Pena MP, Duffau H.
Functional
and oncological outcomes after right hemisphere glioma resection
in awake versus asleep patients: a systematic review and
meta-analysis.
Neurosurg
Rev. 2024 Apr 16;47(1):160. doi:
10.1007/s10143-024-02370-8. PMID:
38625548.
Review˰
ˍ
Zhao X, Li R, Guo Y, Wan H, Zhou D.
Laser
interstitial thermal therapy for recurrent glioblastomas: a
systematic review and meta-analysis.
Neurosurg
Rev. 2024 Apr 16;47(1):159. doi:
10.1007/s10143-024-02409-w. PMID:
38625588.
Review;
Meta-analysis˰
ˍ
Durham PG, Butnariu A, Alghorazi R, Pinton G, Krishna V, Dayton
PA.
Current clinical investigations of
focused ultrasound blood-brain barrier disruption: A
review.
Neurotherapeutics.
2024 Apr 17;21(3):e00352. doi:
10.1016/j.neurot.2024.e00352. PMID:
38636309.
Review.
ˍ
Geng Y, Xie L, Li J, Wang Y, Li X.
Bibliometric
analysis of emerging trends and research foci in brainstem tumor
field over 30 years (1992-2023).
Childs
Nerv Syst. 2024 Apr 17. doi:
10.1007/s00381-024-06404-w. PMID:
38630267. Bibliometric analysis˰
ˍ
*Roda D, Veiga P, Melo JB, Carreira IM, Ribeiro IP.
Principles
in the Management of Glioblastoma.
Genes
(Basel). 2024 Apr 17;15(4):501. doi:
10.3390/genes15040501. PMID:
38674436.
Review.
ˍ
Zheng Y, Ong SH, Nga VDW, Vellayappan B.
Adjuvant
radiotherapy versus observation after gross total resection of WHO
grade II ependymoma: a systematic review and
individual-participant data meta-analysis.
Chin
Clin Oncol. 2024 Apr 17:cco-23-136. doi:
10.21037/cco-23-136. PMID:
38644544. Review; Meta-analysis. ˍ
Zoi V, Kyritsis AP, Galani V, Lazari D, Sioka C, Voulgaris S,
Alexiou GA.
The Role of Curcumin in
Cancer: A Focus on the PI3K/Akt Pathway.
Cancers
(Basel). 2024 Apr 18;16(8):1554. doi:
10.3390/cancers16081554. PMID:
38672636.
Review.
ˍ
Bakker A, Ixkes AE, Venugopal H, Ries MG, Lak NSM, de Vos FYFL,
van Vuurden DG, Snijders TJ.
Focused
Ultrasound-Enhanced Liquid Biopsy: A Promising Diagnostic Tool for
Brain Tumor Patients.
Cancers
(Basel). 2024 Apr 19;16(8):1576. doi: 10.3390/cancers16081576.
PMID:
38672658.
Review.
ˍ
*Frosina G.
Advancements in Image-Based
Models for High-Grade Gliomas Might Be Accelerated.
Cancers
(Basel). 2024 Apr 19;16(8):1566. doi:
10.3390/cancers16081566. PMID:
38672647.
Review.
ˍ
Pećina-Šlaus N, Hrašćan R.
Glioma
Stem Cells-Features for New Therapy Design.
Cancers
(Basel). 2024 Apr 19;16(8):1557. doi:
10.3390/cancers16081557. PMID:
38672638.
Review.
ˍ
Kitagawa Y, Kobayashi A, Cahill DP, Wakimoto H, Tanaka
S.
Molecular biology and novel
therapeutics for IDH mutant gliomas: The new era of IDH
inhibitors.
Biochim
Biophys Acta Rev Cancer. 2024 Apr 21;1879(3):189102.
doi:
10.1016/j.bbcan.2024.189102. PMID:
38653436. Review˰
ˍ
Kappel AD, Jha R, Guggilapu S, Smith WJ, Feroze AH, Dmytriw AA,
Vicenty-Padilla J, Alcedo Guardia RE, Gessler FA, Patel NJ, Du R,
See AP, Peruzzi PP, Aziz-Sultan MA, Bernstock JD.
Endovascular
Applications for the Management of High-Grade Gliomas in the
Modern Era.
Cancers
(Basel). 2024 Apr 22;16(8):1594. doi:
10.3390/cancers16081594. PMID:
38672676.
Review.
ˍ
Oishi T, Koizumi S, Kurozumi K.
Mesenchymal
stem cells as therapeutic vehicles for glioma.
Cancer
Gene Ther. 2024 Apr 23. doi:
10.1038/s41417-024-00775-7. PMID:
38654128. Review˰
ˍ
Wadhwa K, Chauhan P, Kumar S, Pahwa R, Verma R, Goyal R, Singh G,
Sharma A, Rao N, Kaushik D.
Targeting
brain tumors with innovative nanocarriers: bridging the gap
through the blood-brain barrier.
Oncol
Res. 2024 Apr 23;32(5):877-897. doi:
10.32604/or.2024.047278. PMID:
38686045.
Review.
ˍ
Al-Lami BS, Al-Lami BS, Al-Lami YS.
Survival
outcomes after using charged particle radiotherapy as a treatment
modality for gliomas: A systematic review and meta-analysis.
J
Med Imaging Radiat Sci. 2024 Apr
25:S1939-8654(24)00106-1. doi:
10.1016/j.jmir.2024.04.003. PMID:
38670903. Review;
Meta-analysis˰ ˍ
Berro A, Assi A, Farhat M, Hatoum L, Saad JP, Mohanna R, Bechara
AMA, Prince G, Hachem MCR, Zalaquett Z, Kourie HR.
Unlocking
Hope: Anti-VEGFR inhibitors and their potential in glioblastoma
treatment.
Crit
Rev Oncol Hematol. 2024 Apr 25:104365. doi:
10.1016/j.critrevonc.2024.104365. PMID:
38677355. Review˰
ˍ
*Vaz-Salgado MÁ, García BC, Pérez IF,
Munárriz BJ, Domarco PS, González AH, Villar MV,
Caro RL, Delgado MLV, Sánchez JMS.
SEOM-GEINO
clinical guidelines for grade 2 gliomas (2023).
Clin
Transl Oncol. 2024 Apr 25. doi:
10.1007/s12094-024-03456-x. PMID:
38662171. Guidelines. ˍ
Das AK, Sinha M, Singh SK, Chaudhary A, Boro AK, Agrawal M,
Bhardwaj S, Kishore S, Kumari K.
CAR
T-cell therapy: a potential treatment strategy for pediatric
midline gliomas.
Acta
Neurol Belg. 2024 Apr 26. doi:
10.1007/s13760-024-02519-8. PMID:
38669002. Review˰
ˍ
Ritchey
AK
et
al., PDQ Pediatric Treatment Editorial Board.
Childhood
Ependymoma: Patient
Version.
PDQ
Cancer Inf Sum.
2024 Apr 26.
NCBI
Bookshelf ID:
NBK65742. PMID
26389185.
Review. ˍ
Ritchey
AK,
et al., PDQ Pediatric Treatment Editorial Board.
Diffuse
Intrinsic Pontine Glioma (DIPG): Patient Version.
PDQ
Cancer Inf Sum.
2024 Apr 26.
NCBI
Bookshelf ID:
NBK600525. PMID: 38377270.
Review.
ˍ
Boop S, Shimony N, Boop F.
How modern
treatments have modified the role of surgery in pediatric
low-grade glioma.
Childs
Nerv Syst. 2024 Apr 27. doi:
10.1007/s00381-024-06412-w. PMID:
38676718. Review.
ˍ
*